New Thermage for Cellulite Procedure Gets Your Bikini Ready in Just One Treatment

March 31, 2008

Houston (PRWEB) March 31, 2008 — No matter how many trips to the gym or diets a woman endures, stubborn cellulite seems to be a persistent problem. In fact, a recent study by Millennium Research Group showed that 90% of women struggle with some degree of cellulite.

Thermage, Inc. has recently answered many a frustrated woman’s prayers with a new non-invasive cellulite solution that yields results after only one treatment. ThermaTip™ CL is an innovative deep heating treatment being hailed by numerous physicians.

Unlike current cellulite treatments on the market, ThermaTip™ CL produces noticeable results after only one procedure–without surgery, injections or downtime. Read more

Botox and Competitors

March 31, 2008

Dr. Brandith Irwin has been a guest skin expert on The Oprah Winfrey Show and is a board-certified dermatologist in Seattle.


Industry Giants Push Obesity Surgery

March 31, 2008

Medical-device makers, venture capitalists and surgeons are racing to turn a once-controversial weight-loss procedure into the next big thing in elective surgery.

Once dismissed by some surgeons as a gimmick, gastric banding — in which a silicone band is wrapped around the upper stomach to restrict food intake — is now the focus of a fierce competition pitting consumer-products giant Johnson & Johnson against Botox maker Allergan Inc. Venture-capital-backed outpatient centers are popping up to implant the bands. Growing ranks of surgeons are touting the procedure at free public seminars. All see a vast market in a country where diet and exercise programs have failed to slow an obesity epidemic. Read more

Cosmetic Plastic Surgery Spending Increases 9 Percent to $12.4 Billion

March 25, 2008

ARLINGTON HEIGHTS, Ill. – Despite domestic concerns like inflation and a looming home lending crisis, average Americans continue to spend money on plastic surgery. According to the latest procedural statistics report from the American Society of Plastic Surgeons (ASPS), almost 12 million cosmetic plastic surgery procedures were performed in 2007 - a 7 percent increase from 2006 and a 59 percent increase from 2000. Also, 5.1 million reconstructive plastic surgery procedures were performed last year.

“The report tells me Americans are devoted to looking and feeling their best,” said Richard A. D’Amico, MD, ASPS president. “High demand continues for less invasive and relatively less expensive procedures, but there were also promising rebounds in some surgical procedures.”

Numbers of surgical cosmetic procedures remained unchanged from the previous year, with more than 1.8 million procedures performed in 2007. The top five surgical procedures were breast augmentation (348,000, up 6 percent), liposuction (302,000, unchanged), nose reshaping (285,000, down 7 percent), eyelid surgery (241,000, up 3 percent), and tummy tuck (148,000, up 1 percent). Read more

Cosmetic Plastic Surgery Procedures for Ethnic Patients Up 13 Percent in 2007

March 25, 2008

ARLINGTON HEIGHTS, Ill. – Almost a quarter (2,626,700) of cosmetic plastic surgery procedures were performed on ethnic patients in 2007, up 13 percent from last year, including Hispanics, African Americans and Asian Americans, according to statistics released today by the American Society of Plastic Surgeons (ASPS).

Since 2006, cosmetic plastic surgery procedures increased in the following demographic categories: up 8 percent (1,011,000) in Hispanics, up 8 percent (847,800) in African Americans, and up 26 percent (767,800) in Asian Americans.

“A key take-away from this data is that the plastic surgery patient profile is changing,” said ASPS President Richard A. D’Amico, MD. “The majority of patients remain Caucasian women, but it is noteworthy that cosmetic plastic surgery procedures were performed on almost as many Hispanic patients as male patients.” Read more

New Treatment for Cellulite

March 24, 2008

While many patients turn to liposuction to get rid of cellulite, a breakthrough treatment now allows individulas to get rid pf the bulges without going under the knife. Drs. Dale Isaacson and Marilyn Berzin perform this new, virtually painless procedure.


Cosmetic Procedure - Learn About Botox Cosmetic

March 20, 2008

A video Spore Medical produced for American Medical Aesthetics (www.amacorp.com) featuring their work using Botox Cosmetic to remove wrinkles.


Key Legal Issues for Medical Spas and Aesthetic Medical Practices

March 19, 2008

Key Legal Issues for Medical Spas and Aesthetic Medical Practices


Aesthetic medicine requires careful attention to the intersection of corporate practice of medicine, licensing, anti-kickback and fee-splitting considerations, and other legal and regulatory issues. This overview will help you better understand the legal implications of opening a medical spa.

Both physicians who want to either open a medical spa or add aesthetic medical procedures to their existing practice, and entrepreneurs who want to either open a medical spa or incorporate aesthetic medical procedures to a wellness center, can benefit from a better understanding of some of key legal issues involved. These legal issues are common to a variety of practices and organizations that offer emerging therapies beyond conventional medical care, whether in a medical spa or dermal clinic, a holistic health care facility, a wellness center, or an ‘integrative medicine clinic’ that includes complementary and alternative medical treatments (such as acupuncture, massage therapy, and dietary supplement recommendations) in its patient care. Read more

Ipsen and Medicis Announce Submission of Reloxin BLA in Aesthetics to the FDA

March 17, 2008

PARIS and SCOTTSDALE, Ariz., March 17, 2008 (PRIME NEWSWIRE) — Medicis (NYSE:MRX) and Ipsen (Euronext:IPN) today announced that Ipsen has submitted a Biologics License Application (”BLA”) for the botulinum toxin type A, Reloxin(R) (Note 1), in aesthetic indications (glabellar lines) to the U.S. Food and Drug Administration’s (”FDA”) Division of Dermatology and Dental Products, within the Center for Drug Evaluation and Research. This BLA submission by Ipsen is intended to address the concerns cited by the FDA when it declined to file the Reloxin(R) BLA in January 2008, which Medicis had submitted in late 2007. Standard response timeframe from the FDA is expected approximately 10 months following receipt of the Reloxin(R) submission. Subject to approval of the BLA by the FDA, Medicis intends to commercialize Reloxin(R) in the U.S. in accordance with the long-standing arrangement between Medicis and Ipsen. Changes from the original BLA submission relate primarily to sponsorship and ownership of the filing. The substantive elements of the original submission remain unchanged. Read more

U.S. Weight Loss Market To Reach 58 Billion in 2007

March 12, 2008

Marketdata Enterprises, Inc. has released a new 393-page study entitled: “The U.S. Weight Loss and Diet Control Market (9th edition)’. This is a complete analysis of the ten major segments of the U.S. diet “industry”.

With no end in sight for America’s obesity problem, demand remains strong for all kinds of weight loss programs, fueling a $55 billion U.S. industry. America’s estimated 72 million dieters - about 70% of whom try to lose weight by themselves, are fickle and shift from fad to fad diet, as evidenced by the Atkins low-carb mania of 2003-2005. These shifts in dieter preferences spells boom or bust for diet companies,” according to Research Director, John LaRosa. Read more

Next Page »